Moderna plans to offer the COVID-19 vaccine at a price of $50-$60 per course.
Cinda PD-1 sales of 500 million in the second quarter.
Cinda anti-CD47/PD-L1 bispecific antibody Phase I clinical completion of China's first patient administration.
Cinda BioCD47/PD-L1 B2specific Antibody Phase I Clinical Study completed the first patient administration in China.
A billion cockroaches who specialize in kitchen waste digest 50 tons of kitchen waste every day.
The most expensive drug in history sells for more than $50 million a month.
What new options are available for new drugs for Hodgkin's lymphoma after the PD-1 antibody fight?
2020 The World's Top 50 Pharmaceutical Companies and their best-selling drugs.
High-value supplies three-step political reform up to 50% of the price reduction finally to where?
50 billion pharmaceutical "white horse" set to increase growth change "package field" of high capital or out?
Jiangsu intends to significantly reduce the number of chemical enterprises, from 50 to 20 chemical parks.
Jiangxi collection and harvesting program announced: up to 2 home selected the lowest price can take 50% of the volume.
Hengrui PD-L1 monoanti-combination therapy has been approved for clinical use in a wide range of small cell lung cancer.
First sound pharmaceutical industry to Hong Kong listing! Last year's total revenue of 5,037 million yuan Nearly 50 innovative drugs in research.
Merck/Pfizer anti-PD-L1 therapy first-line maintenance treatment bladder cancer in the United States, Japan and Europe into the review!
Important research results focus on new achievements made by scientists in the study of PD-1 therapy!
Three yuan sow accounted for nearly 50%, binary sow price of 5000 yuan / head.
Junshi Bio PD-1 in conjunction with aschitinib treatment mucosal melanoma was qualified by the FDA orphan drug.
Keytruda has been approved for the first PD-1 treatment for NMIBC!
On the second anniversary of the National Health Insurance Administration, 50 policies will affect the pharmaceutical industry.